Paraoxon inhibits GABA uptake in brain synaptosomes

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Gamma-aminobutyric acid (GABA) is a primary inhibitory neurotransmitter in the central nervous system.
• Understanding GABA uptake mechanisms is crucial for neurological research and drug development.
• Paraoxon, an organophosphate, is known to inhibit acetylcholinesterase, but its effects on GABAergic systems require further investigation.

Purpose of the Study:

• To investigate the dose-dependent effects of paraoxon on GABA uptake in rat cerebral cortex synaptosomes.
• To determine the kinetic parameters (K(m) and V(max)) of GABA uptake in the presence of paraoxon.
• To elucidate the cholinergic-dependency and transporter type involved in paraoxon's interaction with GABA uptake.

Main Methods:

• Rat cerebral cortex synaptosomes were isolated.
• GABA uptake assays were performed using varying concentrations of paraoxon.
• Kinetic analysis (K(m), V(max)) was conducted with 1 mM paraoxon.
• Cholinergic agents (acetylcholine, atropine, mecamylamine) and specific transporter inhibitors (DABA for neuronal, beta-alanine for glial) were employed.

Main Results:

• Paraoxon exhibited a biphasic effect: low doses (10(-9)-10(-6)M) increased GABA uptake, while high doses (10(-5)-10(-3)M) decreased it.
• One millimolar paraoxon significantly reduced V(max) but not K(m) of GABA uptake.
• Neuronal GABA uptake inhibitor DABA significantly reduced uptake, while glial inhibitor beta-alanine had no effect, indicating neuronal transporter involvement.
• Cholinergic involvement was suggested but not definitively proven.

Conclusions:

• Paraoxon's effect on GABA uptake is dose-dependent, with inhibition at higher concentrations.
• The data suggest paraoxon acts as a non-competitive antagonist of the neuronal GABA transporter.
• These findings contribute to understanding the neurotoxic mechanisms of organophosphates and their impact on GABAergic neurotransmission.